{rfName}
Ev

Indexed in

License and use

Altmetrics

Grant support

NEMESIS-2 is conducted by the Netherlands Institute of Mental Health and Addiction (Trimbos Institute) in Utrecht. Financial support has been received from the Ministry of Health, Welfare and Sport, with supplementary support from the Netherlands Organization for Health Research and Development (ZonMw). This work was supported by the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). These funding sources had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. Bart PF Rutten was funded by a VIDI award number 91718336 from the Netherlands Scientific Organisation. Drs Guloksuz and van Os are supported by the Ophelia research project, ZonMw grant number: 636340001. Dr O'Donovan is supported by MRC programme grant (G08005009) and an MRC Centre grant (MR/L010305/1).

Analysis of institutional authors

Lopez Saiz, GemmaAuthorBernardo MAuthorMezquida GAuthorAmoretti SAuthorAguilar EjAuthor

Share

October 29, 2020
Publications
>
Article
No

Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway

Publicated to:Psychological Medicine. 52 (10): 1910-1922 - 2022-07-01 52(10), DOI: 10.1017/s0033291720003748

Authors: van Os, Jim; Pries, Lotta-Katrin; ten Have, Margreet; de Graaf, Ron; van Dorsselaer, Saskia; Delespaul, Philippe; Bak, Maarten; Kenis, Gunter; Lin, Bochao D; Luykx, Jurjen J; Richards, Alexander L; Akdede, Berna; Binbay, Tolga; Altinyazar, Vesile; Yalincetin, Berna; Gumus-Akay, Guvem; Cihan, Burcin; Soygur, Haldun; Ulas, Halis; Cankurtaran, Eylem Sahin; Kaymak, Semra Ulusoy; Mihaljevic, Marina M; Petrovic, Sanja Andric; Mirjanic, Tijana; Bernardo, Miguel; Mezquida, Gisela; Amoretti, Silvia; Bobes, Julio; Saiz, Pilar A; Paz Garcia-Portilla, Maria; Sanjuan, Julio; Aguilar, Eduardo J; Luis Santos, Jose; Jimenez-Lopez, Estela; Arrojo, Manuel; Carracedo, Angel; Lopez, Gonzalo; Gonzalez-Penas, Javier; Parellada, Mara; Maric, Nadja P; Atbasoglu, Cem; Ucok, Alp; Alptekin, Koksal; Saka, Meram Can; Arango, Celso; O'Donovan, Michael; Rutten, Bart P F; Guloksuz, Sinan

Affiliations

Adnan Menderes Univ, Fac Med, Dept Psychiat, Aydin, Turkey - Author
Ankara Univ, Brain Res Ctr, Ankara, Turkey - Author
Ankara Univ, Sch Med, Dept Physiol, Ankara, Turkey - Author
Ankara Univ, Sch Med, Dept Psychiat, Ankara, Turkey - Author
Ataturk Training & Res Hosp, Psychiat Clin, Ankara, Turkey - Author
Biomed Res Networking Ctr Mental Hlth CIBERSAM, Madrid, Spain - Author
Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff, Wales - Author
Dokuz Eylul Univ, Fac Med, Dept Psychiat, Izmir, Turkey - Author
Dokuz Eylul Univ, Grad Sch Hlth Sci, Dept Neurosci, Izmir, Turkey - Author
GGNet Mental Hlth, Apeldoorn, Netherlands - Author
Guven Cayyolu Healthcare Campus, Ankara, Turkey - Author
Hosp Virgen Luz, Dept Psychiat, Cuenca, Spain - Author
IDIS, Fdn Publ Galega Med Xenom SERGAS, Santiago De Compostela, Spain - Author
Inst Invest Sanitaria Principado Asturias, Oviedo, Spain - Author
Inst Investigac Biomed August Pi & Sunyer, Barcelona, Spain - Author
Inst Mental Hlth, Belgrade, Serbia - Author
Istanbul Univ, Fac Med, Dept Psychiat, Istanbul, Turkey - Author
Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England - Author
Maastricht Univ Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands - Author
Mental Hlth Serv Principado Asturias, Oviedo, Spain - Author
Middle East Tech Univ, Dept Psychol, Ankara, Turkey - Author
Mondriaan Mental Hlth, FACT, Maastricht, Netherlands - Author
Netherlands Inst Mental Hlth & Addict, Dept Epidemiol, Utrecht, Netherlands - Author
Turkish Federat Schizophrenia Assoc, Ankara, Turkey - Author
Univ Barcelona, Hosp Clin Barcelona, Neurosci Inst, Barcelona Clin Schizophrenia Unit, Barcelona, Spain - Author
Univ Belgrade, Fac Med, Belgrade, Serbia - Author
Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain - Author
Univ Complutense, Hosp Gen Univ Gregorio Maranon, Inst Psychiat & Mental Hlth, Sch Med,Dept Child & Adolescent Psychiat,IiSGM, Madrid, Spain - Author
Univ Oviedo, Sch Med, Dept Psychiat, Oviedo, Spain - Author
Univ Santiago de Compostela, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Grp Med Genom, Santiago De Compostela, Spain - Author
Univ Santiago de Compostela, Inst Invest Sanitaria, Dept Psychiat, Complejo Hosp, Santiago De Compostela, Spain - Author
Univ Utrecht, Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Psychiat, Utrecht, Netherlands - Author
Univ Utrecht, Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Translat Neurosci, Utrecht, Netherlands - Author
Univ Valencia, Hosp Clin Univ Valencia, Sch Med, Dept Psychiat, Valencia, Spain - Author
Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA - Author
See more

Abstract

There is evidence that environmental and genetic risk factors for schizophrenia spectrum disorders are transdiagnostic and mediated in part through a generic pathway of affective dysregulation.We analysed to what degree the impact of schizophrenia polygenic risk (PRS-SZ) and childhood adversity (CA) on psychosis outcomes was contingent on co-presence of affective dysregulation, defined as significant depressive symptoms, in (i) NEMESIS-2 (n = 6646), a representative general population sample, interviewed four times over nine years and (ii) EUGEI (n = 4068) a sample of patients with schizophrenia spectrum disorder, the siblings of these patients and controls.The impact of PRS-SZ on psychosis showed significant dependence on co-presence of affective dysregulation in NEMESIS-2 [relative excess risk due to interaction (RERI): 1.01, p = 0.037] and in EUGEI (RERI = 3.39, p = 0.048). This was particularly evident for delusional ideation (NEMESIS-2: RERI = 1.74, p = 0.003; EUGEI: RERI = 4.16, p = 0.019) and not for hallucinatory experiences (NEMESIS-2: RERI = 0.65, p = 0.284; EUGEI: -0.37, p = 0.547). A similar and stronger pattern of results was evident for CA (RERI delusions and hallucinations: NEMESIS-2: 3.02, p < 0.001; EUGEI: 6.44, p < 0.001; RERI delusional ideation: NEMESIS-2: 3.79, p < 0.001; EUGEI: 5.43, p = 0.001; RERI hallucinatory experiences: NEMESIS-2: 2.46, p < 0.001; EUGEI: 0.54, p = 0.465).The results, and internal replication, suggest that the effects of known genetic and non-genetic risk factors for psychosis are mediated in part through an affective pathway, from which early states of delusional meaning may arise.

Keywords

1st episode psychosischildhood adversitychildhood traumaclinical psychosisenvironmentgeneral-populationgeneticsnegative symptomsnetwork approachpsychiatric-disorderspsychosisschizophrenia spectrum disordersshort-formAffective pathwayChildhood adversityEnvironmentGeneticsMental-health surveyPsychosis

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Psychological Medicine due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position 10/131, thus managing to position itself as a Q1 (Primer Cuartil), in the category Psychology, Clinical. Notably, the journal is positioned above the 90th percentile.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 2.16. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Field Citation Ratio (FCR) from Dimensions: 5.12 (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-21, the following number of citations:

  • WoS: 17
  • Europe PMC: 7

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-21:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 53.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 63 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 5.2.
  • The number of mentions on the social network X (formerly Twitter): 8 (Altmetric).

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Netherlands; Serbia; Turkey; United Kingdom; United States of America.